Nu Skin Enterprises (NUS) Misses Q4 EPS by 4c, provides guidance
Get Alerts NUS Hot Sheet
Revenue Growth %: +3.1%
Financial Fact:
Other income (expense), net: -5.7M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.29, $0.04 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $370.32 million versus the consensus estimate of $392.1 million.
GUIDANCE:
Nu Skin Enterprises sees Q1 2026 EPS of $0.10-$0.20, versus the consensus of $0.27. Nu Skin Enterprises sees Q1 2026 revenue of $320-340 million, versus the consensus of $356.8 million.
Nu Skin Enterprises sees FY2026 EPS of $0.80-$1.20, versus the consensus of $1.42. Nu Skin Enterprises sees FY2026 revenue of $1.35-1.5 billion, versus the consensus of $1.53 billion.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Peloton Interactive (PTON) to Underweight
- Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share